{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T02:57:15Z","timestamp":1781233035141,"version":"3.54.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"DOI":"10.1038\/s41390-026-05179-x","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T02:26:48Z","timestamp":1781231208000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Type I interferon signature does not correlate with disease activity in Blau syndrome"],"prefix":"10.1038","author":[{"given":"Benjamin","family":"Fournier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9lo\u00efse","family":"Reumaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Melki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Uettwiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Labouret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Dumaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Le Lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Labelette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian I.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Seabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Quartier-dit-Maire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Louise","family":"Fr\u00e9mond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Bader-Meunier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Wouters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"5179_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1546-0096-12-33","volume":"12","author":"CH Wouters","year":"2014","unstructured":"Wouters, C. H. et al. Blau Syndrome, the prototypic auto-inflammatory granulomatous disease. Pediatr. Rheumatol. 12, 1\u20139 (2014).","journal-title":"Pediatr. Rheumatol."},{"key":"5179_CR2","first-page":"1","volume":"0","author":"EO Kreps","year":"2024","unstructured":"Kreps, E. O. et al. Long-term visual outcome of patients with Blau syndrome. Ocul. Immunol. Inflamm. 0, 1\u20135 (2024).","journal-title":"Ocul. Immunol. Inflamm."},{"key":"5179_CR3","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ajo.2017.08.017","volume":"187","author":"IL Sarens","year":"2018","unstructured":"Sarens, I. L. et al. Blau syndrome-associated uveitis: preliminary results from an international prospective interventional case series. Am. J. Ophthalmol. 187, 158\u2013166 (2018).","journal-title":"Am. J. Ophthalmol."},{"key":"5179_CR4","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jaci.2017.04.013","volume":"141","author":"S Takada","year":"2018","unstructured":"Takada, S. et al. Pluripotent stem cell models of Blau syndrome reveal an IFN-\u03b3\u2013dependent inflammatory response in macrophages. J. Allergy Clin. Immunol. 141, 339\u2013349.e11 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"5179_CR5","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.jaci.2012.02.004","volume":"129","author":"CEI Janssen","year":"2012","unstructured":"Janssen, C. E. I. et al. Morphologic and immunohistochemical characterization of granulomas in the nucleotide oligomerization domain 2\u2013related disorders Blau syndrome and Crohn disease. J. Allergy Clin. Immunol. 129, 1076\u20131084 (2012).","journal-title":"J. Allergy Clin. Immunol."},{"key":"5179_CR6","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1136\/annrheumdis-2020-217320","volume":"79","author":"T Matsuda","year":"2020","unstructured":"Matsuda, T. et al. Clinical characteristics and treatment of 50 cases of Blau syndrome in Japan confirmed by genetic analysis of the NOD2 mutation. Ann. Rheum. Dis. 79, 1492\u20131499 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"5179_CR7","doi-asserted-by":"publisher","first-page":"810","DOI":"10.3899\/jrheum.2024-0822","volume":"52","author":"Y Hu","year":"2025","unstructured":"Hu, Y. et al. Effective Treatment of Janus Kinase 1\/3 Inhibitor in Blau syndrome from a multicenter retrospective study in central China. J. Rheumatol. 52, 810\u2013816 (2025).","journal-title":"J. Rheumatol."},{"key":"5179_CR8","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12969-021-00634-x","volume":"19","author":"S Zhang","year":"2021","unstructured":"Zhang, S., Cai, Z., Mo, X. & Zeng, H. Tofacitinib effectiveness in Blau syndrome: a case series of Chinese paediatric patients. Pediatr. Rheumatol. 19, 160 (2021).","journal-title":"Pediatr. Rheumatol."},{"key":"5179_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30615-x","volume":"13","author":"W Damsky","year":"2022","unstructured":"Damsky, W. et al. Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis. Nat. Commun. 13, 3140 (2022).","journal-title":"Nat. Commun."},{"key":"5179_CR10","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1093\/rheumatology\/key090","volume":"57","author":"L Wang","year":"2018","unstructured":"Wang, L. et al. S100A12 and S100A8\/9 proteins are biomarkers of articular disease activity in Blau syndrome. Rheumatol. (Oxf.) 57, 1299\u20131304 (2018).","journal-title":"Rheumatol. (Oxf.)"},{"key":"5179_CR11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10875-016-0359-1","volume":"37","author":"GI Rice","year":"2017","unstructured":"Rice, G. I. et al. Assessment of Type I interferon signaling in pediatric inflammatory disease. J. Clin. Immunol. 37, 123\u2013132 (2017).","journal-title":"J. Clin. Immunol."},{"key":"5179_CR12","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201560","volume":"218","author":"A Lepelley","year":"2021","unstructured":"Lepelley, A. et al. Enhanced cGAS-STING-dependent interferon signaling associated with mutations in ATAD3A. J. Exp. Med 218, e20201560 (2021).","journal-title":"J. Exp. Med"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05179-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05179-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05179-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T02:26:49Z","timestamp":1781231209000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05179-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":12,"alternative-id":["5179"],"URL":"https:\/\/doi.org\/10.1038\/s41390-026-05179-x","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Parental consent was obtained for conducting the measurement ISG expression as part of a study approved by the Comit\u00e9 de protection des personnes Ile de France II and the French advisory committee on data processing in medical research (ID-RCB: 2014-A01017-40, revalidated in 2022 and 2025).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent Statement"}}]}}